CERT1 and malignant colon neoplasm: To characterize CERT mutants in the absence of endogenous CERT, we used a HCT116 CERT1 knockout (KO) cell line, in which both alleles of CERT1 were disrupted in human colon-cancer-derived HCT116 cells.